Extract the potential

Lysogene

Associate Sponsor

LYSOGENE is a clinical stage pioneering biotechnology company engaged in providing safe and efficient innovative gene therapy treatments for patients affected with severe neurological diseases. Founded in recent years, LYSOGENE’s business and economic model is based on avant-garde drug development methodologies focused on scientific and medical intelligence, regulatory streamlining, and genuine patient-turned drivers.
LYSOGENE’s princeps product SAF-301, an rAAV vector, aims at treating Mucopol

http://www.lysogene.com/ ›
sponsor now ›
register now ›
back to sponsors list ›

Sponsor World Orphan Drug Congress 2011 ›

Associate Sponsor
Lysogene at World Orphan Drug Congress 2011
Associate Sponsor
Shire Human Genetic Therapies at World Orphan Drug Congress 2011
Associate Sponsor
AVI BioPharma at World Orphan Drug Congress 2011
Associate Sponsor
Oxon Epidemiology at World Orphan Drug Congress 2011
Associate Sponsor
Centric Health Resources at World Orphan Drug Congress 2011
Associate Sponsor
Clinigen Healthcare Limited at World Orphan Drug Congress 2011
Associate Sponsor
Charles River Discovery & Imaging Services at World Orphan Drug Congress 2011
Associate Sponsor
Santhera Pharmaceutical at World Orphan Drug Congress 2011
Associate Sponsor
QCTR Ltd at World Orphan Drug Congress 2011
Associate Sponsor
PSR Group B.V at World Orphan Drug Congress 2011
sponsors list ›

 

The World Orphan Drug Congress is a multi-faceted event

  • A three day conference
  • case studies by industry professionals
  • Speed networking
  • Interactive panel discussions
  • Roundtable brainstorms
  • Live debates

Register now ›
Download prospectus ›

You may also like to attend:

  • European Antibody Congress
  • World Influenza Congress Europe
  • World Vaccine Congress Lyon

See more ›